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1. Introduction 
Streptococcus viridans II belongs to the group of 
Gram-positive, cu-hemolyzing cocci causing septicemia 
and endocarditis n man. Whereas occurrence and 
properties of neuraminidases (sialidase, acylneura- 
minosyl hydrolase, EC 3.2.1.18) in p-hemolyzing 
streptococci are well documented [I-S], little is 
known about hese enzymes inviridescent s rains [6,7]. 
Neur~i~dases cleave cu-ketosidic l nkages between 
~-acylneur~~c acid (NeuAc) and glycoconjugates 
(i.e., oligosaccharides, glycolipids and glycoproteins) 
of vertebrate tissues and are therefore discussed as 
pathogenic factors in microbial infections [a]. They are 
also known to unmask antigenic sites of tumor tissues 
and are already used in cancer immunotherapy [9]. 
Neuraminidases of viral and bacterial origin show 
genus-dependent distinctions in their specificities 
towards different substrates and also in their affmities 
towards different linkage types of NeuAc, i.e., ar2+3, 
(u2+6, and a2+8, to the adjacent c~bohydrate mole- 
cules [lo]. Therefore, further knowledge on microbial 
neuraminidases may enable us to develop better tools 
for structure lucidation of glycoconjugates a well as 
for applications in living systems. 
2. Material and methods 
2.1. Origin of substrates 
3’-Sialyllactose (I13NeuAc-Lac), 6’.sialyllactose, 
(II6 NeuAc-Lac), disialyllactose (113-(+-2&euAc8),- 
Lac), pentaose b (II16NeuA~-hosed), pentaose c 
(IV6 Neu Ac-nooses ) and ~s~yllacto-N-tetraose 
(IV3 NeuAc,II16 NeuAc-LeOsee) were isolated from 
human milk and from cow’s colostrum, respectively, 
as in [ 113. Colominic acid was a generous gift of Dr 
ElsevierfNorth-Holland Biomedical Press 
Y. Uchida, Uji, Japan. Ganglioside G,, = IIJNeuAc- 
GgOseq. Cer and II3 NeuAc-GgOse4 were kindly pro- 
vided by Dr H. Wiegandt, Marburg. Bovine brain gan- 
glioside mixture and fetuin were purchased from Sigma 
Chemical Co., St Louis, MO, al-acid glycoprotein 
(orosomucoid) from Behringwerke AG, Marburg, and 
bovine submaxillary mucin and NeuA$2+methyl- 
glycoside from Boehringer Mannheim GmbH. Neu- 
Ac~2~(3’-me~oxyphenyl)-~ycoside was agift of NIH 
Resources Branch, Bethesda, MD. Human urinary 
glycoprotein was isolated as in [ 121. 
2.2. Preparation of enzymes 
Streptococcus viridans (Biotype II) strains were 
isolated from blood cultures of patients with sepsis 
and were cultivated and typed as in [7]. Cultures 
(24 h) (strain 011785) in tryptose phosphate bouillon 
were centrifuged at 100 000 X g for 30 min. The clear 
supernatants were dialyzed 3 times for 12 h against 
0.03 M b~bital-acetate buffer (pH 6.0) according to 
~~haelis [13 1. The undi~yzable residue was concen- 
trated in an Amicon UM 10 ul~~tration cell to 
l/lOth of its initial volume. The remaining solution 
was fractionated by gel fdtration on a Sephadex G-100 
column (90 X 2.6 cm) equilibrated with Michaelis 
buffer mentioned above. Neuraminidase activities of 
each column fraction were identified as below. Two 
neuraminidase p aks, a higher molecular weight neura- 
minidase I and a lower molecular weight neuramini- 
dase II were identified and readily separated. The two 
enzymes were rechromato~aphed separately on a 
Sephadex G-100 column (90 X 2.6 cm) calibrated with 
standard proteins for molecular weight dete~ination 
and further purification. Protein assays were perform- 
ed by the method in [ 141. Neuraminidase I and II 
were concentrated again and stored at 4O‘C. 
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NeuA~~ont~g substrates were dissolved in 
0.03 M barbitalacetate buffer (pH 6.0) so as to give a 
total of 50 ~g/lOO ~l(’ 1.50 mM) ~y~osidic~Iy 
linked NeuAc in each test. Additional buffer and an 
appropriate amount of enzyme preparation (i.e., 
IO-100 ~1) to 200 ~1 final vol. were added. Incuba- 
tion times were from 15 min to 24 h at 37°C. Blanks 
contained all the ~gredients except he enzyme. 
NeuAc released was determined by the periodic acid/ 
t~ob~biturat~ method according to [ 151. With Neu- 
Ac~2~3’-me~oxyphenyl~~ycoside as substrate, 
neura~nidase activity was tested according to fl6]. 
3. Results and discussion 
In contrast o other streptococcus strains, S. viri- 
dam shows constantly high neuraminidase activities 
even after multiple transfers in vitro. However, enzyme 
production can be stimulated by addition of Sacetyl- 
mannosamine to the culture medium in an optimal 
concentration of 10” M. The enzyme preparation 
shows a remarkable high temperature stability: The 
temperature opium is at 40°C. After 30 mm incu- 
bation time, activity is reduced to 90% at 45”C, to 
SO%at 48OC, to 10% at 52”C, and 5% at 56”C, respec- 
tively. 
Neuraminidase I
60 
0 
2 4 
Incubation time [h] B 
Elution volume [ml] -----w 
Fig. 1. Elution pattern of S. viridans neuraminidases on Sepba- 
dex G-100. Column 90 X 2.6 cm, 0.03 M barbital-acetate 
buffer (pH 6.0). Det~rm~ation of NeuAc released from 
I13NeuAc-Lac by the periodic acid~t~o~rbit~ate method 
according to [IS]. incubation, 14 h at 37°C. 
As shown in fig.1, neur~~da~ a~ti~ty can be 
separated by gel filtration on Sephadex G-100 into 
two fractions, a higher molecular weight neuramini- 
dase I @$86 000) and a lower molecular weight neura- 
Neuraminidase II 
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Fig.2. ReIease of NeuAc from different oliiosaccharides by S. s~i~~~ neuraminidases I and II. Determination of NeuAc released 
as described. (*---0) WNeuAc-Lac; (o- 5) II*NeuAc-Lac; (A---A> I13(+2LuNeuAe8),-Lac; (A---A) IV’ NeuAc-nLcC?se,; 
P--- w) v13NeuAc, III‘ Ne~c-Loses. 
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minidase II (M, 45 000). Considering the molecular 
weights, one could assume enzyme I is a dimer of 
enzyme II. However, as will be pointed out later, both 
enzymes show remarkable differences in their substrate 
type specificities. The pH optima are at 6.5 in veronal- 
acetate buffer for both enzymes. Ca’+ increases the 
enzyme activities over 10-2-10-5M. An inhibition by 
EDTA up to 50% was observed at 5 X 10T2 M. 
Fig.2 shows the cleavage velocities towards NeuAc- 
oligosaccharides. Among the different linkage types 
of NeuAc, both enzymes cleave the a2+3 linkage in 
II3 NeuAc-Lac preferentially, followed by the a2-+8 
linkage in II3 (+-20NeuAc8)2-Lac. The activities to- 
wards the a2+6 linkages in II6 NeuAc-Lac and in 
IV6 NeuAc-n&cOse4 are remarkably low. Despite of 
numerous cr2+=8 linkages, colominic acid and bovine 
brain gangliosides are also little attacked by both en- 
zymes under conditions used in the test. However, in 
contrast to ganglioside G,,, the free oligosaccharide 
II’NeuAc-GgOse4 is cleaved to an extent of 20% 
compared with II3 NeuAc-Lac by enzyme II, indicating 
that the lipid part is mainly responsible for the resis- 
tance of G, l towards neuraminidase actions. 
Fig.3 shows the specificity patterns of S. viridans 
neuraminidase I and II towards the different types of 
substrates under comparable conditions: The higher 
molecular weight enzyme I cleaves globular glyco- 
protein substrates, i.e., human cur-acid glycoprotein 
(orosomucoid) and calf fetuin, preferentially, followed 
by mucous substrates like Tamm-Horsfall urinary gly- 
coprotein and bovine submaxillary mucin. In contrast, 
enzyme II prefers oligosaccharide substrates containing 
a2+3 linkages, whereas the activity towards glyco- 
protein substrates is considerably lower. Mucins are 
hydrolysed very slowly. Synthetic or semi-synthetic 
substrates like NeuAcar2+benzylketoside, NeuAccw2-+ 
(3’-methoxyphenyl)-ketoside or II’NeuAc-Lac methyl 
ester are fairly good substrates for both enzymes, 
whereas NeuAcfl2+methyl-ketoside is not cleaved at 
all, demonstrating that S. viridans neuraminidases are 
or-glycosidases like all other neuraminidases known so 
far. 
In general, the specificity patterns of both enzymes 
are similar to neuraminidases found in bacteria of low 
or mean pathogenicity towards man, i.e., Clostridium 
septicum [ 171, Erysipelothrix rhusiopathiae [ 181 and 
others [ 191. The remarkable affinity of enzyme I 
towards o2+3 linked NeuAc compared with (u2+6 
linkages may be useful for the elucidation of NeuAc- 
linkages in glycoproteins as well as for specific altera- 
tions of cell membrane glycoconjugates. 
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